塔奎他单抗

Talquetamab

Abstract

No information is available on the use of talquetamab during breastfeeding. Because talquetamab is a large protein molecule with a molecular weight of about 147,000 Da, the amount in milk is likely to be very low.[1] It is also likely to be partially destroyed in the infant's gastrointestinal tract and absorption by the infant is probably minimal.[2] The manufacturer recommends that breastfeeding be discontinued during therapy and for 3 months after the last dose.

摘要

关于在母乳喂养期间使用talquetamab的信息尚无可用资料。由于talquetamab是一种分子量约为147,000 Da的大型蛋白质分子，乳汁中的含量可能非常低。[1]它也可能在婴儿胃肠道中被部分破坏，婴儿的吸收可能极少。[2]制造商建议在治疗期间及最后一剂后3个月内停止母乳喂养。